Skip to main content

FDA addresses coronavirus variants in updated guidance for medical developers

The Food and Drug Administration issued new guidance on Monday amid the emergence of new coronavirus variants for medical product developers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.